Medico Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE630Y01024
  • NSEID: MEDICO
  • BSEID: 540937
INR
53.00
-0.4 (-0.75%)
BSENSE

Dec 05

BSE+NSE Vol: 89.0 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Medico Remedies
Everest Organics
Jenburkt Pharma
Haleos Labs Limi
Medicamen Biotec
Albert David
Nectar Lifesci.
Kerala Ayurveda
Solara Active PP
Amanta Healthcar
Influx Health.
Why is Medico Remedies Ltd ?
1
High Management Efficiency with a high ROCE of 15.04%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.89 times
3
The company has declared Positive results for the last 3 consecutive quarters
  • ROCE(HY) Highest at 20.65%
  • PAT(Q) At Rs 2.57 cr has Grown at 65.8%
  • DEBTORS TURNOVER RATIO(HY) Highest at 2.99 times
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Medico Remedies should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Medico Remedies for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Medico Remedies
5.92%
0.11
61.21%
Sensex
4.82%
0.40
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
8.07%
EBIT Growth (5y)
35.36%
EBIT to Interest (avg)
8.34
Debt to EBITDA (avg)
1.08
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
2.30
Tax Ratio
24.97%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.31%
ROCE (avg)
15.69%
ROE (avg)
17.20%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
39
Industry P/E
34
Price to Book Value
6.54
EV to EBIT
36.42
EV to EBITDA
29.22
EV to Capital Employed
5.77
EV to Sales
2.61
PEG Ratio
0.81
Dividend Yield
NA
ROCE (Latest)
15.85%
ROE (Latest)
16.98%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
ROCE(HY)

Highest at 20.65%

PAT(Q)

At Rs 2.57 cr has Grown at 65.8%

DEBTORS TURNOVER RATIO(HY)

Highest at 2.99 times

NET SALES(Q)

Highest at Rs 52.64 cr

-3What is not working for the Company
INVENTORY TURNOVER RATIO(HY)

Lowest at 4.15 times

NON-OPERATING INCOME(Q)

is 49.57 % of Profit Before Tax (PBT

Loading Valuation Snapshot...
Here's what is working for Medico Remedies
Profit After Tax (PAT) - Quarterly
At Rs 2.57 cr has Grown at 65.8%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 52.64 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 52.64 cr has Grown at 33.77%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Debtors Turnover Ratio- Half Yearly
Highest at 2.99 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Medico Remedies
Inventory Turnover Ratio- Half Yearly
Lowest at 4.15 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Non Operating Income - Quarterly
is 49.57 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT